Annual Drug Patent Expirations for DOCETAXEL
Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys Labs Ltd, Hikma, Hong Kong, Hospira Inc, Ingenus Pharms Llc, Jiangsu Hengrui Med, Mylan Labs Ltd, Pfizer Labs, Sandoz, Shilpa, Teva Pharms Usa, and Sun Pharma Global and, and is included in twenty-two NDAs. It is available from thirteen suppliers. There are four patents protecting this drug.
This drug has fifty-two patent family members in twenty-five countries.
The generic ingredient in DOCETAXEL is docetaxel. Thirteen suppliers are listed for this compound. Additional details are available on the docetaxel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
